Plasma membrane microparticles in angiogenesis: Role in ischemic diseases and in cancer

Physiological Research

Volumn 57, Issue 3, 2008, Pages 311-320

  Mostefai, H A ^a   Andriantsitohaina, R ^a   Martínez, M Carmen ^a  

^a Universite d'Angers   (France)

Author keywords

Endothelial cells; Ischemic diseases; Microparticles; Tumor development

Indexed keywords

ANGIOGENESIS; ANIMAL; CELL MEMBRANE; ENDOTHELIUM CELL; HUMAN; ISCHEMIA; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; SHORT SURVEY; TRANSPORT VESICLE; VASCULARIZATION;

ANIMALS; CELL MEMBRANE; ENDOTHELIAL CELLS; HUMANS; ISCHEMIA; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; TRANSPORT VESICLES;

EID: 45849127669     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (70)

1. AGOUNI A, MOTEFAI AH, PORRO C, CARUSIO N, FAVRE J, RICHARD V, HENRION D, MARTINEZ MC, ANDRIANTSITOHAINA R: Sonic hedgehog carried by microparticles corrects endothelial injury through nitric oxide release. FASEB J 21: 2735-2741, 2007.
2. ANDREOLI CM, MILLER JW: Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol. 18: 502-508, 2007.
3. ANGELUCCI A, D'ASCENZO S, FESTUCCIA C, GRAVINA GL, BOLOGNA M, DOLO V, PAVAN A: Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines. Clin Exp Metastasis 18: 163-170, 2000.
4. ASAHARA T, MUROHARA T, SULLIVAN A, SILVER M, VAN DER ZEE R, LI T, WITZENBICHLER B, SCHATTEMAN G, ISNER JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997.
5. ASAHARA T, TAKAHASHI T, MASUDA H, KALKA C, CHEN D, IWAGURO H, INAI Y, SILVER M, ISNER JM: VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18: 3964-3972, 1999.
6. ASAI J, TAKENAKA H, KUSANO KF, II M, LUEDEMANN C, CURRY C, EATON E, IWAKURA A, TSUTSUMI Y, HAMADA H, KISHIMOTO S, THORNE T, KISHORE R, LOSORDO DW: Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell-mediated microvascular remodeling. Circulation 113: 2413-2424, 2006.
7. BAJ-KRZYWORZEKA M, MAJKA M, PRATICO D, RATAJCZAK J, VILAIRE G, KIJOWSKI J, RECA R, JANOWSKA-WIECZOREK A, RATAJCZAK MZ: Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol. 30: 450-459, 2002.
8. BERNAL-MIZRACHI L, JY W, JIMENEZ JJ, PASTOR J, MAURO LM, HORSTMAN LL, DE MARCHENA E, AHN YS: High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 145: 962-970, 2003.
9. BOULANGER CM, SCOAZEC A, EBRAHIMIAN T, HENRY P, MATHIEU E, TEDGUI A, MALLAT Z: Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104: 2649-2652, 2001.
10. BRILL A, DASHEWSKY O, RIVO J, GOZAL Y, VARON D: Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 67: 30-38, 2005.
11. CARMELIET P: Angiogenesis in health and disease. Nat Med 9: 653-660, 2003.
12. DAS SK, VASUDEVAN DM: Essential factors associated with hepatic angiogenesis. Life Sci 81: 1555-1564, 2007.
13. DEREGIBUS MC, CANTALUPPI V, CALOGERO R, LO IACONO M, TETTA C, BIANCONE L, BRUNO S, BUSSOLATI B, CAMUSSI G: Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110: 2440-2448, 2007.
14. DISTLER JH, PISETSKY DS, HUBER LC, KALDEN JR, GAY S, DISTLER O: Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum 52: 3337-3348, 2005.
15. DIXELIUS J, CROSS M, MATSUMOTO T, SASAKI T, TIMPL R, CLAESSON-WELSH L: Endostatin regulates endothelial cell adhesion and cytoskeletal organization. Cancer Res 62: 1944-1947, 2002.
16. DONNINI S, ZICHE M: Constitutive and inducible nitric oxide synthase: role in angiogenesis. Antioxid Redox Signal 4: 817-823, 2002.
17. FOLKMAN J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995.
18. FUKUHARA S: Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer. Lung Cancer 39: 145-149, 2003.
19. FUKUMURA D, GOHONGI T, KADAMBI A, IZUMI Y, ANG J, YUN CO, BUERK DG, HUANG PL, JAIN RK: Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98: 2604-2609, 2001.
20. HELISCH A, SCHAPER W: Arteriogenesis: the development and growth of collateral arteries. Microcirculation 10: 83-97, 2003.
21. HILL J.M., ZALOS G., HALCOX J.P.J., SCHENKE W.H., WACLAWIW M.A., QUYYUMI A.A., FINKEL T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600, 2003.
22. HILLEN F, GRIFFOIOEN AW: Tumor vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev 26: 489-502, 2007.
23. HSU AR, VEERAVAGU A, CAI W, HOU LC, TSE V, CHEN X: Integrin alpha(v)beta(3) antagonists for anti-angiogenic cancer treatment. Recent Patents Anticancer Drug Discov 2: 143-158, 2007.
24. ISNER JM, WALSH K, SYMES J, PIECZEK A, TAKESHITA S, LOWRY J, ROSENFIELD K, WEIR L, BROGI E, JURAYJ D: Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum Gene Ther 7: 959-988, 1996.
25. JANOWSKA-WIECZOREK A, MARQUEZ-CURTIS LA, WYSOCZYNSKI M, RATAJCZAK MZ: Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells. Transfusion 46: 1199-209, 2006.
26. JANOWSKA-WIECZOREK A, WYSOCZYNSKI M, KIJOWSKI J, MARQUEZ-CURTIS L, MACHALINSKI B, RATAJCZAK J, RATAJCZAK MZ: Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 113: 752-760, 2005.
27. KANAZAWA S, NOMURA S, KUWANA M, MURAMATSU M, YAMAGUCHI K, FUKUHARA S: Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer. Lung Cancer 39: 145-149, 2003.
28. KIM CW, LEE HM, LEE TH, KLEINMAN HK, GHO YS: Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res 62: 6312-6317, 2002.
29. KIM HK, SONG KS, PARK YS, KANG YH, LEE YJ, LEE KR, KIM HK, RYU KW, BAE JM, KIM S: Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 39: 184-191, 2003.
30. KIM HK, SONG KS, CHUNG JH, LEE KR, LEE SN: Platelet microparticles induce angiogenesis in vitro. Br J Haematol 124: 376-384, 2004.
31. KOBAYASHI S, SATOH M, NAMIKOSHI T, HARUNA Y, FUJIMOTO S, ARAKAWA S, KOMAI N, TOMITA N, SASAKI T, KASHIHARA N: Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy. Clin Exp Nephrol 12: 119-125, 2008.
32. KUSANO KF, POLA R, MURAYAMA T, CURRY C, KAWAMOTO A, IWAKURA A, SHINTANI S, II M, ASAI J, TKEBUCHAVA T, THORNE T, TAKENAKA H, AIKAWA R, GOUKASSIAN D, VON SAMSON, HAMADA H, YOON YS, SILVER M, EATON E, MA H, HEYD L, KEARNEY M, MUNGER W, PORTER JA, KISHORE R, LOSORDO DW: Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling. Nature Med 11: 1197-1204, 2005.
33. LACROIX R, SABATIER F, MIALHE A, BASIRE A, PANNELL R, BORGHI H, ROBERT S, LAMY E, PLAWINSKI L, CAMOIN-JAU L, GUREWICH V, ANGLES-CANO E, DIGNAT-GEORGE F: Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood. 110: 2432-2439, 2007.
34. LI Y, HAZARIKA S, XIE D, PIPPEN AM, KONTOS CD, ANNEX BH: In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. Diabetes 56: 656-665, 2007.
35. LUQUE CONTRERAS D, VARGAS ROBLES H, ROMO E, RIOS A, ESCALANTE B: The role of nitric oxide in the post-ischemic revascularization process. Pharmacol Ther 112: 553-563, 2006.
36. LUTTUN A., CARMELIET G., CARMELIET P: Vascular progenitors: from biology to treatment. Trends Cardiovasc Med 12: 88-96, 2002.
37. MALLAT Z, BENAMER H, HUGEL B, BENESSIANO J, STEG PG, FREYSSINET JM, TEDGUI A: Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101: 841-843, 2000.
38. MARTIN S, TESSE A, HUGEL B, MARTINEZ MC, MOREL O, FREYSSINET JM, ANDRIANTSITOHAINA R: Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression. Circulation 109: 1653-1659, 2004.
39. MARTINEZ MC, LARBRET F, ZOBAIRI F, COULOMBE J, DEBILI N, VAINCHENKER W, RUAT M, FREYSSINET JM: Transfer of differentiation signal by membrane microvesicles harbouring hedgehog morphogens. Blood 108: 3012-3020, 2006.
40. MARTINEZ MC, TESSE A, ZOBAIRI F, ANDRIANTSITOHAINA R: Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol 288: H1004-H1009, 2005.
41. MEZENTSEV A, MERKS RM, O'RIORDAN E, CHEN J, MENDELEV N, GOLIGORSKY MS, BRODSKY SV: Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol 289: H1106-H1114, 2005.
42. MILLIMAGGI D, MARI M, D'ASCENZO S, CAROSA E, JANNINI EA, ZUCKER S, CARTA G, PAVAN A, DOLO V: Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia 9: 349-357, 2007.
43. MIYAZAKI Y, NOMURA S, MIYAKE T, KAGAWA H, KITADA C, TANIGUCHI H, KOMIYAMA Y, FUJIMURA Y, IKEDA Y, FUKUHARA S: High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 88: 3456-3464, 1996.
44. MOENS AL, GOOVAERTS I, CLAEYS MJ, VRINTS CJ: Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool? Chest 127: 2254-2263, 2005.
45. MORISHITA R, NAKAMURA S, HAYASHI S, TANIYAMA Y, MORIGUCHI A, NAGANO T, TAIJI M, NOGUCHI H, TAKESHITA S, MATSUMOTO K, NAKAMURA T, HIGAKI J, OGIHARA T: Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 33: 1379-1384, 1999.
46. MOSTEFAI AH, AGOUNI A, CARUSIO N, MASTRONARDI L, HEYMES C, HENRION D, ANDRIANTSITOHAINA R., MARTINEZ MC: PI3-Kinase and xanthine oxidase regulate NO and reactive oxygen species production by apoptotic lymphocyte microparticles in endothelial cells. J Immunol 180: 5028-5035, 2008.
47. MOTRO B, ITIN A, SACHS L, KESHET E: Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci USA 87: 3092-3096, 1990.
48. NAPOLI C, BALESTRIERI A, IGNARRO LJ: Therapeutic approaches in vascular repair by adult bone marrow cells and circulating progenitor endothelial cells. Curr Pharm Des 13: 3245-3251, 2007.
49. OGATA N, NOMURA S, SHOUZU A, IMAIZUMI M, ARICHI M, MATSUMURA M: Elevation of monocyte-derived microparticles in patients with diabetic retinopathy. Diabetes Res Clin Pract 73: 241-248, 2006.
50. O'REILLY MS, BOEHM T, SHING Y, FUKAI N, VASIOS G, LANE WS, FLYNN E, BIRKHEAD JR, OLSEN BR, FOLKMAN J: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285, 1997.
51. PARK CC, MOREL JC, AMIN MA, CONNORS MA, HARLOW LA, KOCH AE: Evidence of IL-18 as a novel angiogenic mediator. J Immunol. 167: 1644-1653, 2001.
52. PEPPER MS: Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21: 1104-1117, 2001.
53. POLA R, LING LE, SILVER M, CORBLEY MJ, KEARNEY M, BLAKE PEPINSKY R, SHAPIRO R, TAYLOR FR, BAKER DP, ASAHARA T. ISNER JM: The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med 7: 706-711, 2001.
54. RAFII S: Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest 105: 17-19, 2000.
55. RAFII S, LYDEN D, BENEZRA R, HATTORI K, HEISSIG B: Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy. Nat Rev Cancer 2: 826-835, 2002.
56. SABATIER F, DARMON P, HUGEL B, COMBES V, SANMARCO M, VELUT JG, ARNOUX D, CHARPIOT P, FREYSSINET JM, OLIVER C, SAMPOL J, DIGNAT-GEORGE F: Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 51: 2840-2845, 2002.
57. SCMIDT-LUCKE C, ROSSIG L, FICHTLSCHERER S, VASA M, BRITTEN M, KAMPER U, DIMMELER S, ZEIHER AM: Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111: 2981-2987, 2005.
58. SIMS PJ, WIEDMER T: The response of human platelets to activated components of the complement system. Immunol Today 12: 338-42, 1991.
59. TARABOLETTI G, D'ASCENZO S, BORSOTTI P, GIAVAZZI R, PAVAN A, DOLO V: Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 160: 673-680, 2002.
60. TROYANOVSKY B, LEVCHENKO T, MÅNSSON G, MATVIJENKO O, HOLMGREN L: Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 152: 1247-1254. 2001.
61. VAN DER ZEE PM, BIRÓ E, KO Y, DE WINTER RJ, HACK CE, STURK A, NIEUWLAND R: P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 52: 657-664, 2006.
62. WIEDMER T, SIMS PJ: Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles. Blood 78: 2880-2886, 1991.
63. WILD S, ROGLIC G, GREEN A, SICREE R, KING H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053, 2004.
64. YANG C, MWAIKAMBO BR, ZHU T, GAGNON C, LAFLEUR J, SESHADRI S, LACHAPELLE P, LAVOIE JC, CHEMTOB S, HARDY P: Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways. Am J Physiol 294: R467-R476, 2008.
65. YANO Y, KAMBAYASHI J, SHIBA E, SAKON M, OIKI E, FUKUDA K, KAWASAKI T, MORI T: The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane. Biochem J 299: 303-308, 1994.
66. YU JL, RAK JW: Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. J Thromb Haemost 2: 2065-2067, 2004.
67. ZENT R, POZZI A. Antiangiogenic therapy in diabetic nephropathy. J Am Soc Nephrol 17: 325-327, 2006.
68. ZHANG X, LAWLER J: Thrombospondin-based antiangiogenic therapy. Microvasc Res 74: 90-99, 2007.
69. ZICHE M, MORBIDELLI L, CHOUDHURI R, ZHANG HT, DONNINI S, GRANGER HJ, BICKNELL R: Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99: 2625-2634, 1997.
70. ZIELINSKA M, KONIAREK W, GOCH JH, CEBULA B, TYBURA M, ROBAK T, SMOLEWSKI P: Circulating endothelial microparticles in patients with acute myocardial infarction. Kardiol Pol 62: 531-542, 2005.